» Articles » PMID: 26206626

Medical Costs of Alzheimer's Disease Misdiagnosis Among US Medicare beneficiaries

Overview
Specialties Neurology
Psychiatry
Date 2015 Jul 25
PMID 26206626
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Recent developments in diagnostic technology can support earlier, more accurate diagnosis of non-Alzheimer's disease (AD) dementias.

Methods: To evaluate potential economic benefits of early rule-out of AD, annual medical resource use and costs for Medicare beneficiaries potentially misdiagnosed with AD prior to their diagnosis of vascular dementia (VD) or Parkinson's disease (PD) were compared with that of similar patients never diagnosed with AD.

Results: Patients with prior AD diagnosis used substantially more medical services every year until their VD/PD diagnosis, resulting in incremental annual medical costs of approximately $9,500-$14,000. However, following their corrected diagnosis, medical costs converged with those of patients never diagnosed with AD.

Discussion: The observed correlation between timing of correct diagnosis and subsequent reversal in excess costs is strongly suggestive of the role of misdiagnosis of AD - rather than AD comorbidity - in this patient population. Our findings suggest potential benefits from earlier, accurate diagnosis.

Citing Articles

Factors Associated With Increased Health Care Utilization for Patients With Dementia With Lewy Bodies: A Narrative Review.

Wyman-Chick K, Barrett M, Miller M, Kuntz J, Chrenka E, Rossom R J Patient Cent Res Rev. 2024; 11(2):97-106.

PMID: 39044852 PMC: 11262839. DOI: 10.17294/2330-0698.2059.


Double-Edged Sword: A Positive Brain Scan Result Heightens Confidence in an Alzheimer's Diagnosis But Also Leads to Higher Stigma Among Older Adults in a Vignette-Based Experiment.

Stites S, Lee B, Largent E, Harkins K, Sankar P, Krieger A J Gerontol B Psychol Sci Soc Sci. 2024; 79(8).

PMID: 38869988 PMC: 11237985. DOI: 10.1093/geronb/gbae109.


Strengthening Primary Care Workforce Capacity in Dementia Diagnosis and Care: A Qualitative Study of Project Alzheimer's Disease-ECHO.

Sideman A, Hernandez de Jesus A, Alagappan C, Ma M, Koenig C, Alving L Med Care Res Rev. 2024; 81(5):384-394.

PMID: 38819958 PMC: 11389049. DOI: 10.1177/10775587241251868.


Neuropsychological differential diagnosis of Alzheimer's disease and vascular dementia: a systematic review with meta-regressions.

Sokolovic L, Hofmann M, Mohammad N, Kukolja J Front Aging Neurosci. 2023; 15:1267434.

PMID: 38020767 PMC: 10657839. DOI: 10.3389/fnagi.2023.1267434.


Clinical biomarkers for Lewy body diseases.

Abdelmoaty M, Lu E, Kadry R, Foster E, Bhattarai S, Mosley R Cell Biosci. 2023; 13(1):209.

PMID: 37964309 PMC: 10644566. DOI: 10.1186/s13578-023-01152-x.